Hoque, Kazi Mirajul
Dixon, Eryn E. http://orcid.org/0000-0003-4604-7907
Lewis, Raychel M.
Allan, Jordyn
Gamble, Gregory D.
Phipps-Green, Amanda J. http://orcid.org/0000-0002-1763-9623
Halperin Kuhns, Victoria L. http://orcid.org/0000-0002-6348-7931
Horne, Anne M.
Stamp, Lisa K.
Merriman, Tony R. http://orcid.org/0000-0003-0844-8726
Dalbeth, Nicola http://orcid.org/0000-0003-4632-4476
Woodward, Owen M. http://orcid.org/0000-0001-9514-2180
Funding for this research was provided by:
Manatu Hauora | Health Research Council of New Zealand (14/527, 14/527, 14/527)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01DK114091, 5P30DK090868)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
Article History
Received: 12 June 2019
Accepted: 6 May 2020
First Online: 2 June 2020
Competing interests
: In the last 3 years, N.D. has received speaking fees from Pfizer, Horizon, Janssen, and AbbVie; consulting fees from Horizon, Hengrui, and AstraZeneca; and research funding from Amgen and AstraZeneca. No other authors declare any competing interests.